Treovir Inc.
Bala Cynwyd, PA
- UEI
- P3MKE8JK22Q8
- CAGE
- 8C8X4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 128 Penarth Rd, Bala Cynwyd, PA 19004, USA
- Website
- treovir.com
- Founded
- 2019
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase II clinical trial of G207 HSV to treat children with high grade gliomas | National Cancer Institute (NIH) | $2,932,957 |
Quick answers
Is Treovir Inc. registered in SAM.gov?
Yes. Treovir Inc.'s SAM.gov registration is active through November 17, 2026.
What is Treovir Inc.'s most recent federal award?
Treovir Inc.'s most recent federal grant award is Phase II clinical trial of G207 HSV to treat children with high grade gliomas (R44CA250883), from National Cancer Institute (NIH), on September 1, 2020.
On GovTribe
See Treovir Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors